GEU2003994Y - Protobe (HA-protobe)-Hydroxyapatite - Google Patents

Protobe (HA-protobe)-Hydroxyapatite

Info

Publication number
GEU2003994Y
GEU2003994Y GEAU2002001103U GEU2003994Y GE U2003994 Y GEU2003994 Y GE U2003994Y GE AU2002001103 U GEAU2002001103 U GE AU2002001103U GE U2003994 Y GEU2003994 Y GE U2003994Y
Authority
GE
Georgia
Prior art keywords
protobe
hydroxyapatite
protobes
paradontite
stomatology
Prior art date
Application number
Inventor
Tamara Okropiridze
Tato Gabisonia
George Menabde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to GEAU2002001103 priority Critical patent/GEU2003994Y/en
Publication of GEU2003994Y publication Critical patent/GEU2003994Y/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. Technical Result Increase in assortment of the means for treating paradontite, prevention of side-effects. 2. Essence A means for treatment comprises sterile hydroxyapatite and a combination of protobes. 3. Field of Application Medicine, stomatology.
GEAU2002001103 2002-11-22 2002-11-22 Protobe (HA-protobe)-Hydroxyapatite GEU2003994Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAU2002001103 GEU2003994Y (en) 2002-11-22 2002-11-22 Protobe (HA-protobe)-Hydroxyapatite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAU2002001103 GEU2003994Y (en) 2002-11-22 2002-11-22 Protobe (HA-protobe)-Hydroxyapatite

Publications (1)

Publication Number Publication Date
GEU2003994Y true GEU2003994Y (en) 2003-06-10

Family

ID=45477461

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAU2002001103 GEU2003994Y (en) 2002-11-22 2002-11-22 Protobe (HA-protobe)-Hydroxyapatite

Country Status (1)

Country Link
GE (1) GEU2003994Y (en)

Similar Documents

Publication Publication Date Title
HRP20020593B1 (en) Brain, spinal and nerve injury treatment
MXPA03003960A (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders.
EP2087892A3 (en) (S,S) reboxetine for treating age associated learning and mental disorders
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
DE69636989D1 (en) BIOACTIVE LOAD-CARRYING COMPOSITIONS FOR THE BONE ASSOCIATION
EP0955018A3 (en) Valve for medical appliances
GB2288732B (en) Pharmaceutical compositions
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
PL378369A1 (en) Method of treating nausea, vomiting, retching or any combination thereof
HK1047707A1 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
CA2340021A1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
GB0020504D0 (en) Therapeutic method
EP0744176A3 (en) Methods for inhibiting bone loss
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
GEU2003994Y (en) Protobe (HA-protobe)-Hydroxyapatite
AU5434899A (en) Cancer treatment
NZ502022A (en) Shaped products for medical purposes formed from coral of species Acropora
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
EP1472376A4 (en) Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
UA32314A (en) Method for treating necrotic pancreatitis
UA34333A (en) Method for treating severe dental fluorosis
GEP20094628B (en) (s,s)-reboxetine for treating fibromyalgia and other somatoform disorders
WO1998024421A3 (en) Use of dextrin sulphate for the treatment of highly vascular tumours
HK1058305A1 (en) Combinations of dalfopristine/quinupristine with cefpirome